Internal Medicine, Endocrinology, Diabetes, & Metabolism · Greenbelt, MD
NPI
1821452749
Since 2016
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
7501 Greenway Center Dr Ste 730
Greenbelt, MD, 20770
Phone (301) 474-0400
Groups this clinician bills Medicare through
Medicare paid, 2024
$89K
2,288 services
Medicare patients, 2024
361
Average age 72
Drug cost, 2024
$1.8M
2,092 prescriptions
Company payments, 2025
$2,441
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sabreen Ahmed was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 554 times for 319 patients. In total Sabreen Ahmed billed 2,288 services in 14 codes, and Medicare paid $89K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-18.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 554 | 319 | $13.56 | $7,512 |
| 99214 Office E&M - Established | Office | 461 | 251 | $98.91 | $46K |
| 82962 Clinical Chemistry | Office | 446 | 197 | $3.11 | $1,386 |
| 83036 Blood Count | Office | 394 | 183 | $9.18 | $3,617 |
| 99213 Office E&M - Established | Office | 206 | 154 | $68.22 | $14K |
| 99204 Office E&M - New | Office | 86 | 86 | $120.68 | $10K |
| 95251 Test - Miscellaneous | Office | 72 | 36 | $25.40 | $1,829 |
| 10005 Other Organ Systems | Office | 27 | 25 | $106.64 | $2,879 |
| 99212 Office E&M - Established | Office | 22 | 20 | $44.89 | $988 |
By year: 2022 $44K for 751 services; 2023 $90K for 1,814 services; 2024 $89K for 2,288 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 446 | 197 | $3.11 | $1,386 |
| 83036 Blood Count | 394 | 183 | $9.18 | $3,617 |
Medicare prescription drug claims, 2024
In 2024, the drug Sabreen Ahmed prescribed most often to Medicare patients was Ozempic (Semaglutide), with 202 prescriptions and refills. In total Sabreen Ahmed wrote 2,092 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 202 | 355 | 54 | $334K |
| Levothyroxine Sodium Generic | 194 | 462 | 54 | $1,931 |
| Metformin Hcl Er Metformin Hcl | 177 | 429 | 54 | $2,499 |
| Mounjaro Tirzepatide | 163 | 228 | 32 | $240K |
| Jardiance Empagliflozin | 148 | 278 | 39 | $156K |
| Trulicity Dulaglutide | 137 | 236 | 36 | $220K |
| Glipizide Er Glipizide | 81 | 207 | 26 | $1,370 |
| Metformin Hcl Generic | 71 | 188 | 24 | $416 |
| Rybelsus Semaglutide | 69 | 141 | 24 | $128K |
| Methimazole Generic | 57 | 125 | 20 | $799 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 56 | 136 | 33 | $7,165 |
| Tresiba Flextouch U-200 Insulin Degludec | 54 | 128 | 19 | $59K |
| Cinacalcet Hcl Generic | 48 | 68 | 11 | $14K |
| Farxiga Dapagliflozin Propanediol | 33 | 74 | 14 | $40K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 32 | 84 | 11 | $46K |
Brand drugs: 1,196 claims; generic drugs: 788 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sabreen Ahmed $2,441 ($2,441 in general payments such as food, travel and fees) from 26 companies. The largest payer was CeQur Corporation with $288.
| Company | Payments | Amount |
|---|---|---|
| CeQur Corporation | 1 | $288 |
| Xeris Pharmaceuticals, Inc. | 15 | $280 |
| Lilly USA, LLC LLY | 16 | $274 |
| Novo Nordisk Inc NVO | 11 | $238 |
| Sanofi-Aventis U.S. LLC SNY | 8 | $184 |
| Corcept Therapeutics CORT | 7 | $164 |
| Amneal Pharmaceuticals LLC AMRX | 7 | $152 |
| Amphastar Pharmaceuticals, Inc. AMPH | 6 | $122 |
| Madrigal Pharmaceuticals MDGL | 6 | $107 |
| Abbvie Inc. ABBV | 3 | $61.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.